Original story from Karolinska Institutet (Stockholm, Sweden). The immune system’s reaction to the common Epstein-Barr virus (EBV) can ultimately damage the brain and contribute to multiple sclerosis (MS). This is shown by new research from Karolinska Institutet (Stockholm, Sweden), published in...
Original story from Universitätsklinikum Bonn (Germany). Breakthrough in retinal organoid research as researchers create vascular networks that enhance survival and function of retinal cells. Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended...
“I think there’s common ground here,” one Republican congressman said Wednesday during a House Budget Committee hearing. Squaring up against healthcare monopolies would be a major pivot for the GOP.
Continue reading →
Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U.S. but has murky sales prospects.
Continue reading →
Novo shares have surged more than 20% amid oral Wegovy’s fast start. Elsewhere, Terns opened up room for a potential partnership and Corcept solidified its case for an ovarian cancer drug.
Continue reading →
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed a year of changes at the Department of Health and Human Services and its Centers for Disease Control and Prevention on NPR’s 1A on Jan. 22. On CBS News 24/7’s The Daily Report on Jan. 16 and CBS...
Luego de un año de brotes continuos de sarampión que han enfermado a más de 2.400 personas, Estados Unidos está a punto de perder su estatus como país libre de sarampión. Sin embargo, el recién nombrado subdirector principal de los Centros para el Control y la...